review Open AccessTop 1% cited
Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases
Journal of Allergy and Clinical Immunology · 2016 · Vol. 138(4) · pp. 984–1010
Mübeccel Akdiş✉Alar Aab(University of Zurich)Can Altunbulakli(University of Zurich)Kursat A Azkur(University of Zurich)Rita Costa(University of Zurich)Reto Crameri(University of Zurich)Su Duan(University of Zurich)Thomas Eiwegger(University of Zurich)Andrzej Eljaszewicz(University of Zurich)Ruth Ferstl(University of Zurich)Remo Frei(University of Zurich)Mattia Garbani(University of Zurich)Anna Głobińska(University of Zurich)Lena Hess(University of Zurich)Carly Huitema(University of Zurich)Terufumi Kubo(University of Zurich)Zsolt István Komlósi(University of Zurich)Patricia Konieczna(University of Zurich)Nóra Kovács(University of Zurich)Umut Can Küçüksezer(University of Zurich)Norbert Meyer(University of Zurich)Hideaki Morita(University of Zurich)Judith Olzhausen(University of Zurich)Liam O’Mahony(University of Zurich)Marija Pezer(University of Zurich)Moira Prati(University of Zurich)Ana Rebane(University of Zurich)Claudio Rhyner(University of Zurich)Arturo Rinaldi(University of Zurich)Milena Sokołowska(University of Zurich)Barbara Stanić(University of Zurich)Kazunari Sugita(University of Zurich)Angela Treis(University of Zurich)Willem van de Veen(University of Zurich)Kerstin Wanke(University of Zurich)Marcin Wawrzyniak(University of Zurich)Paulina Wawrzyniak(University of Zurich)Oliver F. Wirz(University of Zurich)Josefina Zakzuk(University of Zurich)Cezmi A. Akdiş(University of Zurich)
IL-33, ST2, and ILC PathwaysAsthma and respiratory diseasesImmune Cell Function and InteractionImmune systemImmunologyTumor necrosis factor alphaBiologyReceptorCytokineInterleukinTransforming growth factorInflammationCell biology
MeSH terms
AnimalsHumansImmune System DiseasesInterferonsInterleukinsTumor Necrosis Factor-alphaTransforming Growth Factor betaT-Lymphocytes, Regulatory
Funding
- GlaxoSmithKline
- Novartis
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Seventh Framework Programme
Citations
873
FWCI
27.67
field-weighted impact
References
224
Percentile
100%
vs. same field & year
Citations per year
Cited by
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
Frontiers in Immunology · 2020 · 628 citations
Type 2 immunity in the skin and lungs
Allergy · 2020 · 534 citations
References
Inflammasomes: mechanism of action, role in disease, and therapeutics
Nature Medicine · 2015 · 3,158 citations
A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R
The Journal of Immunology · 2002 · 1,281 citations
IL-28, IL-29 and their class II cytokine receptor IL-28R
Nature Immunology · 2002 · 1,559 citations
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Journal of Allergy and Clinical Immunology · 2011 · 762 citations
IL-27, a Heterodimeric Cytokine Composed of EBI3 and p28 Protein, Induces Proliferation of Naive CD4+ T Cells
Immunity · 2002 · 1,454 citations
Viral infection and Toll‐like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte‐derived dendritic cells
European Journal of Immunology · 2004 · 479 citations
The 3 major types of innate and adaptive cell-mediated effector immunity
Journal of Allergy and Clinical Immunology · 2014 · 800 citations
An endotoxin-induced serum factor that causes necrosis of tumors.
Proceedings of the National Academy of Sciences · 1975 · 4,513 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.